We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of RPC1063 in Relapsing Multiple Sclerosis Patients (Radiance Study)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01628393
First Posted: June 26, 2012
Last Update Posted: July 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Celgene
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 3, 2016
  Primary Completion Date: April 15, 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: May 4, 2016
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):